Target Name: MIR190A
NCBI ID: G406965
Review Report on MIR190A Target / Biomarker Content of Review Report on MIR190A Target / Biomarker
MIR190A
Other Name(s): mir-190a | microRNA 190a | miR-190 | hsa-miR-190a-5p | MicroRNA 190a | hsa-mir-190a | MIR190 | MIRN190 | hsa-miR-190a-3p

MIR190A: A Potential Drug Target and Biomarker

Mir190A, a non-coding RNA molecule, has been identified as a potential drug target and biomarker in various diseases, including cancer, neurodegenerative diseases, and respiratory diseases. Its unique structure, expression, and function make it an intriguing candidate for further research and development as a drug.

Structure and Expression

Mir190A is a non-coding RNA molecule, which means it does not have a defined primary or secondary structure. However, its expression and localization to specific tissues and cells suggest that it plays an important role in gene regulation and cell signaling. Mir190A is typically expressed in various tissues, including brain, heart, lungs, and intestine, and its levels vary depending on the specific disease state.

Function

Mir190A is involved in various signaling pathways, including cell signaling, cell growth, and cell death. Its functions are likely due to its unique structure, which allows it to interact with various proteins and factors in the cell. Mir190A has been shown to play a role in the regulation of cell adhesion, migration, and invasion, as well as in the regulation of cell survival and apoptosis.

Mir190A as a Drug Target

The potential drug target for Mir190A is its involvement in cell signaling and its functions in various signaling pathways. Drugs that target Mir190A have the potential to treat various diseases, including cancer, neurodegenerative diseases, and respiratory diseases.

One of the main advantages of targeting Mir190A is its potential to disrupt multiple signaling pathways, making it a versatile target for drug development. For example, Mir190A has been shown to play a role in the regulation of cell adhesion, which is crucial for the development and maintenance of tissues and organs. Targeting Mir190A has been shown to inhibit the formation of cancer cells and reduce their migration and invasion.

Another potential drug target for Mir190A is its role in cell apoptosis, which is a natural mechanism for cell death that helps prevent tissue damage and cancer growth. Mir190A has been shown to regulate cell apoptosis, which may make it a potential target for drugs that promote or inhibit apoptosis.

Mir190A as a Biomarker

Mir190A may also be used as a biomarker for various diseases. Its unique expression patterns and functions make it an attractive candidate for diagnostic tests and therapies. For example, Mir190A has been shown to be downregulated in various diseases, including cancer, neurodegenerative diseases, and respiratory diseases. Targeting Mir190A may be a promising approach for the development of new diagnostic tests and therapies.

Conclusion

Mir190A is a non-coding RNA molecule that has been identified as a potential drug target and biomarker in various diseases. Its unique structure, expression, and functions make it an intriguing candidate for further research and development as a drug. Further studies are needed to determine the exact mechanisms of Mir190A's functions and its potential as a drug target and biomarker.

Protein Name: MicroRNA 190a

The "MIR190A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR190A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR190B | MIR191 | MIR1910 | MIR1911 | MIR1912 | MIR1913 | MIR1914 | MIR1915 | MIR1915HG | MIR192 | MIR193A | MIR193B | MIR193BHG | MIR194-1 | MIR194-2 | MIR194-2HG | MIR195 | MIR196A1 | MIR196A2 | MIR196B | MIR197 | MIR1972-1 | MIR1972-2 | MIR1973 | MIR1976 | MIR198 | MIR199A1 | MIR199A2 | MIR199B | MIR19A | MIR19B1 | MIR19B2 | MIR200A | MIR200B | MIR200C | MIR200CHG | MIR202 | MIR202HG | MIR203A | MIR203B | MIR204 | MIR205 | MIR2052 | MIR2052HG | MIR2053 | MIR2054 | MIR205HG | MIR206 | MIR208A | MIR208B | MIR20A | MIR20B | MIR21 | MIR210 | MIR210HG | MIR211 | MIR2110 | MIR2113 | MIR2114 | MIR2115 | MIR2116 | MIR2117 | MIR212 | MIR214 | MIR215 | MIR216A | MIR216B | MIR217 | MIR217HG | MIR218-1 | MIR218-2 | MIR219A1 | MIR219A2 | MIR219B | MIR22 | MIR221 | MIR222 | MIR223 | MIR224 | MIR2276 | MIR2277 | MIR2278 | MIR22HG | MIR2355 | MIR2392 | MIR23A | MIR23AHG | MIR23B | MIR23C | MIR24-1 | MIR24-2 | MIR2467 | MIR25 | MIR2681 | MIR2682 | MIR26A1 | MIR26A2 | MIR26B | MIR27A | MIR27B